GL1X · GenesisL1 explorer

MolNFT v1 · #191399 · protein

IRAK4 in complex with compound #3

8DKS · Interleukin-1 receptor-associated kinase 4: “IRAK4 in complex with compound #3”. X-ray diffraction, 1 ligand (SO9), 4 pockets (best druggability 0.82). MolNFT v1 #191399 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
8DKS
Type
protein
Length
561 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Interleukin-1 receptor-associated kinase 4
EC
2.7.11.1
UniProt
Q9NWZ3
Ligands
SO9
Pockets
4 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein28341% helix, 17% strandQ9NWZ3
BInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein27842% helix, 17% strandQ9NWZ3

Ligands and binding sites

  • SO9 · (1S,2S,3R,4R)-3-({2-[3-(pyrrolidine-1-carbonyl) anilino]thieno[3,2-d]pyrimidin-4-yl}amino) bicyclo[2.2.1]hept-5-ene-2-carboxamide · ligand · 2 copies · chains A, B
  • BME · Beta-mercaptoethanol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19860.820.83102SO9, BME
22870.670.8238SO9
31030.640.8930empty
4630.590.9024empty

Interfaces

1 interface between chains.

  • A–B · 555 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 modified (additive adduct, phosphorylation).

Compared structures

  • 8DKS · IRAK4 in complex with compound #3 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.